Big Pharma-Backed Dems Join GOP to Block Sanders Effort to End Drug Price Gouging
Sen. Cory Booker and others draw sharp rebuke from observers, who pointed out that many who voted "no" receive substantial contributions from the pharmaceutical industry
While the Republican Party is publicly dismantling millions of Americans' health safety net, more than a dozen Democrats late Wednesday quietly threw their weight behind Big Pharma and voted down an amendment that would have allowed pharmacists to import identical--but much less expensive--drugs from Canada and other countries.
The "power and wealth of the pharmaceutical industry and their 1,300 lobbyists and unlimited sums of money have bought the United States Congress," Sen. Bernie Sanders (I-Vt.) declared in a speech on the Senate floor while introducing the amendment, co-sponsored by Sen. Amy Klobuchar (D-Minn.), which would have been attached to the chamber's budget resolution. It came amid a flurry of legislative activity during Wednesday evening's "vote-a-rama."
"Year after year the same old takes place: the pharmaceutical industry makes more and more money and the American people pay higher ad higher prices," Sanders continued, asking his colleagues if they "have the guts finally to stand up to the pharmaceutical industry and their lobbyists and their campaign contributions and fight for the American consumer?"
It turns out, no.
In fact, 13 Democrats voted against the measure (roll call here), siding with the Republican majority and drawing sharp rebuke from observers, who pointed out that many who voted "no" receive substantial contributions from the pharmaceutical industry.
@Lauren_Steiner @davidsirota Donnelly (absurd history of bad votes of this issue), Heinrich (HillaryMan), Heitkamp (anti-ACA)...
-- Siobhan Rampling (@Mayafacetico) January 12, 2017
@Lauren_Steiner @davidsirota Menendez (pharma money), Murray (pharma money), Tiller (???), Warner (VIRGINIA DEMOCRATS!), & Our Dear Cory
-- Siobhan Rampling (@Mayafacetico) January 12, 2017
Many were particularly dismayed that Sen. Cory Booker (D-N.J.) had sided with Big Pharma after winning liberal praise for his unprecedented testimony against Attorney General nominee Sen. Jeff Sessions (R-Ala.). Notably, 12 Republicans and two Independents, including Sanders, voted for the measure.
Seventy-two percent of Americans support such a rule, according to Sanders, who noted that the price differences between the U.S. and Canada are "dramatic."
"EpiPen, for example, costs more than $600 in the United States compared to $290 in Canada for the exact same allergy treatment," a press statement from Sanders' office observed. "A popular drug for high cholesterol, Crestor, costs $730 in the U.S. but $160 across the northern border. Abilify, a drug to treat depression, is more than $2,636 for a 90-day supply in the U.S. but only $436 in Canada."
Sanders' attempt to attach such a provision to the 21st Century Cures Act last month was similarly blocked.
Should the import rule have passed, it would have been a step towards ending "the epidemic of price gouging," Sanders said, which has become a hot-button issue for many Americans who are unable to afford their prescription drugs--a point the former presidential candidate hammered home on Twitter ahead of the vote.
Urgent. It's never been this bad.
Dear Common Dreams reader, It’s been nearly 30 years since I co-founded Common Dreams with my late wife, Lina Newhouser. We had the radical notion that journalism should serve the public good, not corporate profits. It was clear to us from the outset what it would take to build such a project. No paid advertisements. No corporate sponsors. No millionaire publisher telling us what to think or do. Many people said we wouldn't last a year, but we proved those doubters wrong. Together with a tremendous team of journalists and dedicated staff, we built an independent media outlet free from the constraints of profits and corporate control. Our mission from the outset was simple. To inform. To inspire. To ignite change for the common good. Building Common Dreams was not easy. Our survival was never guaranteed. When you take on the most powerful forces—Wall Street greed, fossil fuel industry destruction, Big Tech lobbyists, and uber-rich oligarchs who have spent billions upon billions rigging the economy and democracy in their favor—the only bulwark you have is supporters who believe in your work. But here’s the urgent message from me today. It’s never been this bad out there. And it’s never been this hard to keep us going. At the very moment Common Dreams is most needed and doing some of its best and most important work, the threats we face are intensifying. Right now, with just three days to go in our Spring Campaign, we're falling short of our make-or-break goal. When everyone does the little they can afford, we are strong. But if that support retreats or dries up, so do we. Can you make a gift right now to make sure Common Dreams not only survives but thrives? There is no backup plan or rainy day fund. There is only you. —Craig Brown, Co-founder |
While the Republican Party is publicly dismantling millions of Americans' health safety net, more than a dozen Democrats late Wednesday quietly threw their weight behind Big Pharma and voted down an amendment that would have allowed pharmacists to import identical--but much less expensive--drugs from Canada and other countries.
The "power and wealth of the pharmaceutical industry and their 1,300 lobbyists and unlimited sums of money have bought the United States Congress," Sen. Bernie Sanders (I-Vt.) declared in a speech on the Senate floor while introducing the amendment, co-sponsored by Sen. Amy Klobuchar (D-Minn.), which would have been attached to the chamber's budget resolution. It came amid a flurry of legislative activity during Wednesday evening's "vote-a-rama."
"Year after year the same old takes place: the pharmaceutical industry makes more and more money and the American people pay higher ad higher prices," Sanders continued, asking his colleagues if they "have the guts finally to stand up to the pharmaceutical industry and their lobbyists and their campaign contributions and fight for the American consumer?"
It turns out, no.
In fact, 13 Democrats voted against the measure (roll call here), siding with the Republican majority and drawing sharp rebuke from observers, who pointed out that many who voted "no" receive substantial contributions from the pharmaceutical industry.
@Lauren_Steiner @davidsirota Donnelly (absurd history of bad votes of this issue), Heinrich (HillaryMan), Heitkamp (anti-ACA)...
-- Siobhan Rampling (@Mayafacetico) January 12, 2017
@Lauren_Steiner @davidsirota Menendez (pharma money), Murray (pharma money), Tiller (???), Warner (VIRGINIA DEMOCRATS!), & Our Dear Cory
-- Siobhan Rampling (@Mayafacetico) January 12, 2017
Many were particularly dismayed that Sen. Cory Booker (D-N.J.) had sided with Big Pharma after winning liberal praise for his unprecedented testimony against Attorney General nominee Sen. Jeff Sessions (R-Ala.). Notably, 12 Republicans and two Independents, including Sanders, voted for the measure.
Seventy-two percent of Americans support such a rule, according to Sanders, who noted that the price differences between the U.S. and Canada are "dramatic."
"EpiPen, for example, costs more than $600 in the United States compared to $290 in Canada for the exact same allergy treatment," a press statement from Sanders' office observed. "A popular drug for high cholesterol, Crestor, costs $730 in the U.S. but $160 across the northern border. Abilify, a drug to treat depression, is more than $2,636 for a 90-day supply in the U.S. but only $436 in Canada."
Sanders' attempt to attach such a provision to the 21st Century Cures Act last month was similarly blocked.
Should the import rule have passed, it would have been a step towards ending "the epidemic of price gouging," Sanders said, which has become a hot-button issue for many Americans who are unable to afford their prescription drugs--a point the former presidential candidate hammered home on Twitter ahead of the vote.
While the Republican Party is publicly dismantling millions of Americans' health safety net, more than a dozen Democrats late Wednesday quietly threw their weight behind Big Pharma and voted down an amendment that would have allowed pharmacists to import identical--but much less expensive--drugs from Canada and other countries.
The "power and wealth of the pharmaceutical industry and their 1,300 lobbyists and unlimited sums of money have bought the United States Congress," Sen. Bernie Sanders (I-Vt.) declared in a speech on the Senate floor while introducing the amendment, co-sponsored by Sen. Amy Klobuchar (D-Minn.), which would have been attached to the chamber's budget resolution. It came amid a flurry of legislative activity during Wednesday evening's "vote-a-rama."
"Year after year the same old takes place: the pharmaceutical industry makes more and more money and the American people pay higher ad higher prices," Sanders continued, asking his colleagues if they "have the guts finally to stand up to the pharmaceutical industry and their lobbyists and their campaign contributions and fight for the American consumer?"
It turns out, no.
In fact, 13 Democrats voted against the measure (roll call here), siding with the Republican majority and drawing sharp rebuke from observers, who pointed out that many who voted "no" receive substantial contributions from the pharmaceutical industry.
@Lauren_Steiner @davidsirota Donnelly (absurd history of bad votes of this issue), Heinrich (HillaryMan), Heitkamp (anti-ACA)...
-- Siobhan Rampling (@Mayafacetico) January 12, 2017
@Lauren_Steiner @davidsirota Menendez (pharma money), Murray (pharma money), Tiller (???), Warner (VIRGINIA DEMOCRATS!), & Our Dear Cory
-- Siobhan Rampling (@Mayafacetico) January 12, 2017
Many were particularly dismayed that Sen. Cory Booker (D-N.J.) had sided with Big Pharma after winning liberal praise for his unprecedented testimony against Attorney General nominee Sen. Jeff Sessions (R-Ala.). Notably, 12 Republicans and two Independents, including Sanders, voted for the measure.
Seventy-two percent of Americans support such a rule, according to Sanders, who noted that the price differences between the U.S. and Canada are "dramatic."
"EpiPen, for example, costs more than $600 in the United States compared to $290 in Canada for the exact same allergy treatment," a press statement from Sanders' office observed. "A popular drug for high cholesterol, Crestor, costs $730 in the U.S. but $160 across the northern border. Abilify, a drug to treat depression, is more than $2,636 for a 90-day supply in the U.S. but only $436 in Canada."
Sanders' attempt to attach such a provision to the 21st Century Cures Act last month was similarly blocked.
Should the import rule have passed, it would have been a step towards ending "the epidemic of price gouging," Sanders said, which has become a hot-button issue for many Americans who are unable to afford their prescription drugs--a point the former presidential candidate hammered home on Twitter ahead of the vote.